195 related articles for article (PubMed ID: 36371022)
21. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases.
Brunsell TH; Sveen A; Bjørnbeth BA; Røsok BI; Danielsen SA; Brudvik KW; Berg KCG; Johannessen B; Cengija V; Abildgaard A; Guren MG; Nesbakken A; Lothe RA
Clin Colorectal Cancer; 2020 Mar; 19(1):e26-e47. PubMed ID: 31982351
[TBL] [Abstract][Full Text] [Related]
22. Clonal origins and parallel evolution of regionally synchronous colorectal adenoma and carcinoma.
Kim TM; An CH; Rhee JK; Jung SH; Lee SH; Baek IP; Kim MS; Lee SH; Chung YJ
Oncotarget; 2015 Sep; 6(29):27725-35. PubMed ID: 26336987
[TBL] [Abstract][Full Text] [Related]
23. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
[TBL] [Abstract][Full Text] [Related]
24. High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer.
Jeantet M; Tougeron D; Tachon G; Cortes U; Archambaut C; Fromont G; Karayan-Tapon L
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916952
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.
Normanno N; Rachiglio AM; Lambiase M; Martinelli E; Fenizia F; Esposito C; Roma C; Troiani T; Rizzi D; Tatangelo F; Botti G; Maiello E; Colucci G; Ciardiello F;
Ann Oncol; 2015 Aug; 26(8):1710-4. PubMed ID: 25851630
[TBL] [Abstract][Full Text] [Related]
27. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
[TBL] [Abstract][Full Text] [Related]
28. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
[TBL] [Abstract][Full Text] [Related]
29. The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.
Afzali F; Akbari P; Naderi-Manesh H; Gardaneh M
Breast Cancer Res Treat; 2019 Jun; 175(2):277-286. PubMed ID: 30810866
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition.
Jungwirth J; Urbanova M; Boot A; Hosek P; Bendova P; Siskova A; Svec J; Kment M; Tumova D; Summerova S; Benes Z; Buchler T; Kohout P; Hucl T; Matej R; Vodickova L; van Wezel T; Vodicka P; Vymetalkova V
Sci Rep; 2022 Feb; 12(1):2570. PubMed ID: 35173208
[TBL] [Abstract][Full Text] [Related]
31. Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt T; Hufnagl C; Weinstock DM; Kopp N; Neureiter D; Tränkenschuh W; Hackl H; Weiss L; Rinnerthaler G; Hartmann TN; Greil R; Weigert O; Egle A
Oncotarget; 2016 Aug; 7(32):51494-51502. PubMed ID: 27285986
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer.
Shi J; Wang L; Yin X; Wang L; Bo L; Liu K; Feng K; Lin S; Xu Y; Ning S; Zhao H
J Transl Med; 2022 Aug; 20(1):362. PubMed ID: 35962343
[TBL] [Abstract][Full Text] [Related]
33. Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications.
Saoudi González N; Salvà F; Ros J; Baraibar I; Rodríguez-Castells M; García A; Alcaráz A; Vega S; Bueno S; Tabernero J; Elez E
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627048
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
Palomba G; Doneddu V; Cossu A; Paliogiannis P; Manca A; Casula M; Colombino M; Lanzillo A; Defraia E; Pazzola A; Sanna G; Putzu C; Ortu S; Scartozzi M; Ionta MT; Baldino G; Sarobba G; Capelli F; Sedda T; Virdis L; Barca M; Gramignano G; Budroni M; Tanda F; Palmieri G
J Transl Med; 2016 Oct; 14(1):292. PubMed ID: 27737711
[TBL] [Abstract][Full Text] [Related]
35. Clonal evolution in long-term follow-up patients with hepatocellular carcinoma.
Chen G; Cai Z; Li Z; Dong X; Xu H; Lin J; Chen L; Zhang H; Liu X; Liu J
Int J Cancer; 2018 Dec; 143(11):2862-2870. PubMed ID: 30183077
[TBL] [Abstract][Full Text] [Related]
36. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma.
Hao JJ; Lin DC; Dinh HQ; Mayakonda A; Jiang YY; Chang C; Jiang Y; Lu CC; Shi ZZ; Xu X; Zhang Y; Cai Y; Wang JW; Zhan QM; Wei WQ; Berman BP; Wang MR; Koeffler HP
Nat Genet; 2016 Dec; 48(12):1500-1507. PubMed ID: 27749841
[TBL] [Abstract][Full Text] [Related]
37. Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia.
de Smith AJ; Ojha J; Francis SS; Sanders E; Endicott AA; Hansen HM; Smirnov I; Termuhlen AM; Walsh KM; Metayer C; Wiemels JL
Oncotarget; 2016 Nov; 7(45):72733-72745. PubMed ID: 27683039
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution.
Braxton DR; Zhang R; Morrissette JD; Loaiza-Bonilla A; Furth EE
Int J Cancer; 2016 Oct; 139(7):1546-56. PubMed ID: 27194209
[TBL] [Abstract][Full Text] [Related]
39. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
[No Abstract] [Full Text] [Related]
40. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
